2022 4th Annual International Congress on the Future of Neurology
Released On
November 10, 2022
Expires On
November 10, 2023
Media Type
Internet
Completion Time
11 hours, 45 minutes
Specialty
Neurology
Topic(s)
Alzheimer Disease, ALS, Epilepsy, Insomnia, Migraine, Multiple Sclerosis, Parkinson's & Movement Disorders, Stroke
input class="btn btn-primary" name="Poster" onclick="window.open('https://www.freecme.com/products/faqs-in-ms-exploring-provocative-questions-from-ms-meeting-updates');" target="_blank" type="button" value="Access Part 5: FAQs in MS: Exploring Provocative Questions From MS Meeting Updates " />
input class="btn btn-primary" name="Poster" onclick="window.open('https://https://www.freecme.com/products/the-expanding-role-of-fluid-biomarkers-in-the-diagnosis-and-management-of-patients-with-alzheimer-disease');" target="_blank" type="button" value="Access Part 6: The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease " />
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
/div>
/div>This activity is supported by educational grants from Biogen, Kyowa Kirin, and Sanofi.
Credit Available
- Physicians — maximum of 11.75 AMA PRA Category 1 Credits™
- Nurses — 11.75 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is directed toward physicians who treat patients with neurologic disorders. Fellows, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the management of patients with neurologic disorders are also invited to participate.
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in the field of neurology. The two-day 2022 4th Annual International Congress on the Future of Neurology showcases the most recent advancements in neurologic disorders in a highly practical and engaging format. In this educational program, these experts discuss the impact of new evidence and novel agents in the treatment of neurologic disorders through a mix of clinical data presentations, case-based discussions, and robust Q&A sessions. A comprehensive overview of pharmacological and nonpharmacological modalities is also presented.
This educational activity is an archive of the live virtual symposium held from September 23-24, 2022.
Learning Objectives
- li>Outline current and emerging diagnostic concepts for neurologic disorders li>Explain clinical evidence for the management of neurologic disorders across multiple lines of care li>Summarize the mechanism of action of therapeutic agents used to manage neurologic disorders li>Prepare strategies for early recognition and management of treatment-related toxicities associated with neurologic therapies li>Apply multidisciplinary care strategies for optimizing patient outcomes in the setting of neurologic disorders li>Assess recent landmark data from clinical trials in the context of evolving treatment paradigms in neurology
Faculty
Jessica Ailani, MD, FAHS, FAAN
Director, MedStar Georgetown Headache Center
Vice Co-Chair, Strategic Planning
MedStar Neurology
Clinical Professor of Neurology
MedStar Georgetown University Hospital
Washington, DC
Richard S. Isaacson, MD
Director, FAU Center for Brain Health and the Alzheimer’s Prevention Clinic
Schmidt College of Medicine
Florida Atlantic University
Boca Raton, FL
Stephen Krieger, MD, FAAN
Professor of Neurology
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, NY
Rory Abrams, MD
Assistant Professor of Neurology
Mount Sinai Hospital, Mount Sinai West, and
Mount Sinai Morningside
New York, NY
Karthikeyan M. Arcot, MD
Clinical Assistant Professor of Neurology
NYU Grossman School of Medicine
New York, NY
Cynthia E. Armand, MD
Assistant Professor of Neurology
Albert Einstein College of Medicine
Program Director, Montefiore Headache Center
Interim Clinical Director, Montefiore Headache Center
Bronx, NY
Patricia K. Coyle, MD
Professor of Neurology
Vice Chair, Clinical Affairs
Department of Neurology
Director, Stony Brook MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, NY
Gayatri Devi, MD, MS, FAAN
Clinical Professor of Neurology
SUNY Downstate Medical Center
Attending Physician
Lenox Hill Hospital/Northwell Health
Zucker School of Medicine at Hofstra/Northwell
Founder and Director
Park Avenue Neurology
New York, NY
Karl Doghramji, MD, FAASM, DFAPA
Professor of Psychiatry, Neurology, and Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University Hospital
Philadelphia, PA
Jeffrey S. Fine, MD, FAAPMR
Associate Professor of Rehabilitation Medicine
Grossman NYU School of Medicine
Vice Chair, Network Development
Rusk Rehabilitation
New York, NY
Vice Chair and Chief, Physical Medicine and Rehabilitation Service
NYU Langone Hospital-Brooklyn
Brooklyn, NY
Jennifer A. Frontera, MD
Professor of Neurology
NYU Grossman School of Medicine
New York, NY
Stuart Isaacson, MD
Director and Founder, Parkinson’s Disease and Movement
Disorders Center of Boca Raton
Medical Director, Parkinson’s Research and Education Foundation
Director, Boca Raton Institute for Neurodegenerative Disorders
Boca Raton, FL
Brad C. Klein, MD, MBA
Medical Director, Abington Headache Center
Chief Financial Officer, Abington Neurological Associates
Jefferson Health–Abington
Abington, PA
Clinical Associate Professor of Neurology
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
Pavel Klein, MD, FAAN, FAES
Director
Mid-Atlantic Epilepsy and Sleep Center
Clinical Professor of Neurology
George Washington University
Bethesda, MD
Katherine E. Leaver, MD
Assistant Professor of Neurology, Movement Disorders
Icahn School of Medicine at Mount Sinai
New York, NY
Erin Longbrake, MD, PhD
Assistant Professor of Neurology
Program Director, Neuroimmunology Fellowship
Director, Clinical Research in Neuroimmunology
Yale School of Medicine
New Haven, CT
Fred D. Lublin, MD, FAAN, FANA
Saunders Family Professor of Neurology
Director, The Corinne Goldsmith Dickinson
Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, NY
Lara Marcuse, MD
Associate Professor of Neurology and Neurophysiology
Co-Director, Mount Sinai Epilepsy Program
Icahn School of Medicine at Mount Sinai
New York, NY
Charles M. Morin
Full Professor of Psychology
Laval University
Director
Centre D’etude des Troubles du Sommeil
Institut Universitaire en Sante Mentale de Quebec
Canada Research Chair in Sleeping Disorders
Cervo Brain Research Centre
Laval University
Québec, Canada
Stephanie J. Nahas, MD, MSEd, FAHS, FAAN
Director, Headache Fellowship Program
Associate Professor of Neurology
Thomas Jefferson University
Philadelphia, PA
Kellyann Niotis, MD
Preventive Neurologist
Early Medical
New York, NY
Marwan N. Sabbagh, MD, FAAN
Professor of Neurology
Barrow Neurological Institute
Phoenix, AZ
Stephen Scelsa, MD
Professor of Neurology
Icahn School of Medicine at Mount Sinai
Cofounder and Director
Beth Israel Medical Center/ALS Association NY Chapter ALS Center
Mount Sinai Health
New York, NY
David M. Simpson, MD, FAAN
Professor of Neurology
Director, Clinical Neurophysiology Laboratories, Neuromuscular Diseases Division, and the Neuro-AIDS Program
Icahn School of Medicine at Mount Sinai
New York, NY
Stewart J. Tepper, MD
Director of Research
Dartmouth Headache Clinic
Professor of Neurology
Dartmouth Geisel School of Medicine
Lebanon, NH
Paula Voinescu, MD, PhD
Neurologist/Epileptologist
Brigham and Women’s Hospital
Assistant Professor of Neurology
Harvard Medical School
Boston, MA
Daniel Weintraub, MD
Professor of Psychiatry
University of Pennsylvania School of Medicine
Parkinson’s Disease Research, Education and
Clinical Center
Philadelphia Veterans Affairs Medical Center
Philadelphia, PA
Phyllis C. Zee, MD, PhD
Director, Center for Circadian and Sleep Medicine
Chief, Sleep Medicine in the Department of Neurology
Benjamin and Virginia T. Boshes Professor of Neurology
Professor of Neurology (Sleep Medicine)
Feinberg School of Medicine
Northwestern University
Evanston, IL
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 11.75 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.
- Jessica Ailani, MD, FAHS, FAAN
- Grant/Research Support: AbbVie, Biohaven, Eli Lilly, Satsuma, Zosano (2021)
- Consultant: AbbVie, Aeon, Lundbeck, Amgen, Eli Lilly, Axsome, GlaxoSmithKline, Satsuma, Impel, Theranica, Teva, Biohaven, Nesos (2022), Neurolief
- Shareholder: Ctrl M Health (2022)
- Richard S. Isaacson, MD
- Consultant: Acadia, Avanair, Biogen, Novo Nordisk, Roche/Genentech
- Stephen Krieger, MD, FAAN
- Grant/Research Support: BMS, Biogen, Novartis
- Consultant: Biogen, EMD Serono, Genentech, Novartis, Octave, Genzyme/Sanofi, TG Therapeutics
- Speaker’s Bureau: Nonpromotional Speaking: Biogen, EMD Serono, and Genentech
Rory Abrams, MD, has no relevant financial relationships with ineligible companies.
Karthikeyan M. Arcot, MD, has no relevant financial relationships with ineligible companies.
- Cynthia E. Armand, MD
- Consultant: AbbVie, Teva, Biohaven
- Patricia K. Coyle, MD
- Grant/Research Support: Celgene, CorEvitas LLC, Genentech/Roche, NINDS, Sanofi Genzyme
- Consultant: Accordant, Biogen, Bristol Myers Squibb, Celgene, GlaxoSmithKline, Horizon Therapeutics, Janssen, Mylan, Novartis, Sanofi Genzyme, TG Therapeutics, Viela Bio
- Speaker’s Bureau: Biogen (nonbranded), Janssen (nonbranded)
- Gayatri Devi, MD, MS, FAAN
- Other: Medical Advisory Board, 98point6
- Karl Doghramji, MD, FAASM, DFAPA
- Grant/Research Support: Inspire, Nyxoah
- Consultant: Idorsia, Jazz, Harmony, Inspire, Eisai, Imbrium, Purdue, Axsome
- Shareholder: Merck
Jeffrey S. Fine, MD, FAAPMR, has no relevant financial relationships with ineligible companies.
- Jennifer A. Frontera, MD
- Grant/Research Support: Portola/Astra Zeneca ANNEXA-I site PI
- Stuart Isaacson, MD
- Grant/Research Support: AbbVie, Acadia, Acorda, Adamas, Addex, Amneal, Aptinyx, Axial, Benevolent, Biogen, BioVie, Cadent, Cala, Cerecor, Cerevel, Eli Lilly, Enterin, Global Kinetics, Impax, Intec Pharma, Jazz, Kyowa Kirin, Lundbeck, Michael J. Fox Foundation, Neuralys, Neurocrine, Neuroderm, Novartis, Parkinson Study Group, Pharma2B, Praxis, Prilenia, Revance, Roche, Sage, Sanofi, Scion, Stoparkinson, Sunovion, Sun Pharma, Supernus, Teva, Theravance, Transposon, UCB
- Consultant: AbbVie, Acadia, Acorda, Adamas, Addex, AFFiRiS, Alexza, Allergan, Amneal, Britannia, Cala, Cerecor, Cerevel, Enterin, GE Healthcare, Global Kinetics, Impax, Impel, Kyowa Kirin, Lundbeck, Merz, Neurocrine, Neuroderm, Pharma2B, Revance, Roche, Sage, Scion NeuroStim, Stoparkinson, Sunovion, Supernus, Teva, UCB
- Speaker’s Bureau: AbbVie, Acadia, Acorda, Adamas, Allergan, Amneal, Kyowa Kirin, Neurocrine, Sunovion, Supernus, Teva
- Brad C. Klein, MD, MBAY
- Grant/Research Support: AbbVie
- Consultant: Amgen, AbbVie, Biohaven, Eli Lilly, Promius, Lundbeck
- Speaker’s Bureau: AbbVie, Amgen, Teva, Pernix Therapeutics, Biohaven, Promius, Theranica, Eli Lilly li>
- Pavel Klein, MD, FAAN, FAES
- Consultant: Aquestive, Arvelle, Neurelis, SK Life Sciences, Sunovion, UCB Pharma
- Speaker’s Bureau: Aquestive, Eisai, Neurelis, Sunovion, SK Life Sciences, UCB Pharma
Katherine E. Leaver, MD, has no relevant financial relationships with ineligible companies.
- Erin Longbrake, MD, PhD
- Grant/Research Support: Genentech
- Consultant: Genentech, Genzyme, Alexion, Biogen, EMD Serono, Janssen, TG Therapeutics, BMS
- Fred D. Lublin, MD, FAAN, FANA
- Grant/Research Support: Novartis, Actelion, Biogen, Sanofi, NMSS, NIH, Brainstorm Cell Therapeutics
- Consultant: Biogen, EMD Serono, Novartis; Teva, Actelion/Janssen, Sanofi/Genzyme, Acorda, Roche/Genentech, MedImmune/Viela Bio/Horizon Therapeutics, Receptos/Celgene/BMS, TG Therapeutics, MedDay, Atara Biotherapeutics, Mapi Pharma, Apitope, Orion Biotechnology, Brainstorm Cell Therapeutics, Jazz Pharmaceuticals, GW Pharma, Mylan, Immunic, Population Council, Avotres, Neurogene, Banner Life Sciences, Labcorp, Entelexo Biotherapeutics, NeuraLight, Setpoint Medical
- Speaker’s Bureau: Sanofi (nonpromotional) li>
- Lara Marcuse, MD
- Speaker’s Bureau: NeuroPace
- Charles M. Morin, PhD
- Grant/Research Support: Eisai, Lallemand
- Consultant: Eisai, Idorsia, Pear Therapeutics, Sunovion
- Shareholder: BeHealth Solutions li>
- Stephanie J. Nahas, MD, MSEd, FAHS, FAAN
- Grant/Research Support: Teva (inactive)
- Consultant: Alder/Lundbeck, Allergan/AbbVie, Amgen/Novartis, Axsome, BioDelivery Sciences, Biohaven, Eli Lilly, Fenix Group International, Impel, Nesos Corp (formerly Vorso Corp), Teva
- Speaker’s Bureau: Allergan/AbbVie, Amgen/Novartis, Eli Lilly, Teva (all inactive)
Kellyann Niotis, MD, has no relevant financial relationships with ineligible companies.
- Marwan N. Sabbagh, MD, FAAN
- Grant/Research Support: NIH, Keep Memory Alive Foundation
- Consultant: Alzheon, Biogen, Neurotrope, Roche-Genentech, Cortexyme, Danone, Stage 2 Innovations, Acadia
- Shareholder: Brain Health Inc, NeuroReserve, NeuroTau, Optimal Cognitive Health Company, uMETHOD Health, Versanum, Athira
- Stephen Scelsa, MD
- Grant/Research Support: AB Science, Sanofi, Drug Trials
- Consultant: Amylyx
- David M. Simpson, MD, FAAN
- Grant/Research Support: Allergan, Ipsen, Merz
- Consultant: Allergan, Ipsen, Merz, Averitas
- Speaker’s Bureau: Averitas
- Stewart J. Tepper, MD
- Grant/Research Support: (no personal compensation): Allergan/AbbVie, Amgen, Eli Lilly,Lundbeck, Neurolief, Novartis, Satsuma, Zosano
- Consultant: Aeon, Allergan/AbbVie, AlphaSights, Amgen, Aruene, Atheneum, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, ClearView Healthcare Partners, Click Therapeutics, Collegium, CoolTech, CRG, Decision Resources, Defined Health, DRG, Eli Lilly, ExpertConnect, FCB Health, Fenix, GLG, Guidepoint Global, Health Advances, Health Science Communications, HMP Communications, Impel, Interactive Forums, KeyQuest Health, Krog & Partners, Lundbeck, M3 Global Research, Magnolia Innovation, MJH Holdings, NeuroFront Therapeutics, Neurolief, Novartis, P Value Communications, Pain Insights, Palion Medical, Pulmatrix, Putnam Associates, SAI MedPartners, Satsuma, Slingshot Insights, Spherix Global Insights, Strategy Inc, System Analytic, Taylor and Francis, Teva, Theranica, Tremeau, Trinity Partners, Unity HA, XOC, Zosano.
- Paula Voinescu, MD, PhD
- Grant/Research Support: Karger Fund, NINDS for MONEAD
- Other: Speaker Honoraria: Neurodiem Workshop and Grand Rounds at Stony Brook University
- Daniel Weintraub, MD
- Grant/Research Support: Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Therapeutic Research Initiative (ATRI), Alzheimer's Disease Cooperative Study (ADCS), International Parkinson and Movement Disorder Society (IPMDS), National Institute on Health (NIH), Parkinson's Foundation, US Department of Veterans Affairs and Acadia Pharmaceuticals
- Consultant: Michael J. Fox Foundation for Parkinson's Research, ATRI, ADCS, IPMDS, NIH, Parkinson's Foundation; US Department of Veterans Affairs and Acadia Pharmaceuticals
- Other: license fee payments from the University of Pennsylvania for the QUIP and QUIP-RS
- Phyllis C. Zee, MD, PhD
- Grant/Research Support: Vanda
- Consultant: Eisai, Jazz, Harmony
- Shareholder: Teva
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
ol>Complete the activity (including pre- and post-activity assessments). li>Answer the evaluation questions. li>Request credit using the drop-down menu. ou may immediately download your certificate.Course Viewing Requirements
Supported Browsers:
nternet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
oogle Chrome 28.0+ for Windows, Mac OS, or Linux
ozilla Firefox 23.0+ for Windows, Mac OS, or Linux
afari 6.0+ for Mac OSX 10.7 and above
/p>
Supported Phones & Tablets:
ndroid 4.0.3 and above
Phone/iPad with iOS 6.1 or above
/p>
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
AHC Media LLC, freeCME.com • P.O. Box 550669 • Atlanta GA, 30326 • 1-800-688-2421
Copyright © 2004-Present. All rights reserved.
Privacy Policy |
Terms of Use
Design, CMS, Hosting & Web Development ::
ePublishing
Powered by the Rievent Platform™ ::
Rievent Technologies
© Copyright 2017 Rievent Technologies. All rights reserved. Powered by the Rievent Platform™.